JP2025011201A5 - - Google Patents

Download PDF

Info

Publication number
JP2025011201A5
JP2025011201A5 JP2024177043A JP2024177043A JP2025011201A5 JP 2025011201 A5 JP2025011201 A5 JP 2025011201A5 JP 2024177043 A JP2024177043 A JP 2024177043A JP 2024177043 A JP2024177043 A JP 2024177043A JP 2025011201 A5 JP2025011201 A5 JP 2025011201A5
Authority
JP
Japan
Prior art keywords
receptor
substitution
killer cell
antigen
hiv antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024177043A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025011201A (ja
Filing date
Publication date
Priority claimed from JP2022500950A external-priority patent/JP7700093B2/ja
Application filed filed Critical
Publication of JP2025011201A publication Critical patent/JP2025011201A/ja
Publication of JP2025011201A5 publication Critical patent/JP2025011201A5/ja
Pending legal-status Critical Current

Links

JP2024177043A 2019-07-08 2024-10-09 多反応性が低下した抗hivワクチン抗体 Pending JP2025011201A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962871393P 2019-07-08 2019-07-08
US62/871,393 2019-07-08
JP2022500950A JP7700093B2 (ja) 2019-07-08 2020-07-08 多反応性が低下した抗hivワクチン抗体
PCT/US2020/041138 WO2021007285A1 (en) 2019-07-08 2020-07-08 Anti-hiv vaccine antibodies with reduced polyreactivity

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022500950A Division JP7700093B2 (ja) 2019-07-08 2020-07-08 多反応性が低下した抗hivワクチン抗体

Publications (2)

Publication Number Publication Date
JP2025011201A JP2025011201A (ja) 2025-01-23
JP2025011201A5 true JP2025011201A5 (enExample) 2025-03-03

Family

ID=74114255

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022500950A Active JP7700093B2 (ja) 2019-07-08 2020-07-08 多反応性が低下した抗hivワクチン抗体
JP2024177043A Pending JP2025011201A (ja) 2019-07-08 2024-10-09 多反応性が低下した抗hivワクチン抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022500950A Active JP7700093B2 (ja) 2019-07-08 2020-07-08 多反応性が低下した抗hivワクチン抗体

Country Status (9)

Country Link
US (1) US12459990B2 (enExample)
EP (1) EP3997119A4 (enExample)
JP (2) JP7700093B2 (enExample)
KR (1) KR20220047977A (enExample)
CN (1) CN114641488A (enExample)
AU (1) AU2020311902A1 (enExample)
CA (1) CA3146372A1 (enExample)
TW (1) TW202116800A (enExample)
WO (1) WO2021007285A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024097957A1 (en) * 2022-11-03 2024-05-10 Duke University Novel antibodies for hiv and methods of making and using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013090644A2 (en) * 2011-12-13 2013-06-20 California Institute Of Technology Anti-hiv antibodies having increased potency and breadth
WO2014205491A1 (en) 2013-06-25 2014-12-31 Monash University Biological molecules and methods of use
US20180028658A1 (en) 2015-02-16 2018-02-01 New York Blood Center, Inc. Antibody-drug conjugates for reducing the latent hiv reservoir
US10450368B2 (en) * 2015-03-19 2019-10-22 Duke University HIV-1 neutralizing antibodies and uses thereof (CD4bs antibodies)
CA2983034A1 (en) * 2015-04-17 2016-10-20 Igm Biosciences, Inc. Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof
EA201891186A1 (ru) * 2015-12-15 2018-12-28 Джилид Сайэнс, Инк. Антитела, нейтрализующие вирус иммунодефицита человека
US11845787B2 (en) 2017-03-27 2023-12-19 The Wistar Institute Of Anatomy And Biology DNA antibody constructs for use against HIV
PE20210685A1 (es) * 2018-07-03 2021-04-08 Gilead Sciences Inc Anticuerpos que se dirigen al gp120 de vih y metodos de uso

Similar Documents

Publication Publication Date Title
CN108610420B (zh) 抗cd19的人源化抗体以及靶向cd19的免疫效应细胞
CN105669863B (zh) 一种能与人内皮素受体特异性结合的抗体及其应用
TWI593706B (zh) 抗αβTCR抗體
CA3199447A1 (en) Fusions with cd8 antigen binding molecules for modulating immune cell function
TW201920258A (zh) 靶向hiv gp120及cd3之多特異性抗體
JP2018533371A5 (enExample)
US12247072B2 (en) IL-21 polypeptides and targeted constructs
KR20170012347A (ko) 삼중-특이적 결합 분자 및 그것의 사용 방법
JP2018526028A5 (enExample)
JP2025011201A5 (enExample)
JP2022540918A (ja) ETA抗体及びTGF-β Trapの融合タンパク質及びその医薬組成物並びに用途
CA3205830A1 (en) Prostate cancer chimeric antigen receptors
US20210246194A1 (en) Optimized gp41-Binding Molecules and Uses Thereof
US20250339519A1 (en) Combination of cytokine fusion proteins with cd8 antigen binding molecules
JP2019048804A (ja) 抗pd−1抗体並びにその治療及び診断のための使用
JPWO2022245500A5 (enExample)
WO2022253240A1 (en) Antibodies targeting afp peptide/mhc complexes and uses thereof
WO2022206857A1 (zh) 一种能与人内皮素受体特异性结合的抗体及其在糖尿病肾病和慢性肾病治疗中的应用
JPWO2020006568A5 (enExample)
EP4323400A1 (en) Taci/bcma dual binding molecules
JPWO2021060932A5 (enExample)